Can adding nerve glides to shoulder therapy ease stubborn neck pain?
NCT ID NCT07724665
First seen Jul 24, 2026 · Last updated Jul 24, 2026
Summary
This trial investigates whether adding neural mobilization—gentle nerve-gliding techniques—to standard scapulothoracic (shoulder blade) therapy can better reduce pain and improve function in people with cervicobrachialgia, a condition causing neck pain that radiates into the arm. Forty-four adults aged 30 to 50 with cervicobrachial pain will receive either scapulothoracic intervention alone or combined with neural mobilization. The study measures changes in pain severity, disability, and nerve sensitivity over the treatment period.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- scapulothoracic intervention with neural mobilization
- What this could lead to
- If effective, this combination therapy could offer a better non-drug option for managing neck and arm pain.
- What could go wrong
- This is a small, early-stage trial with 44 participants, so results may not apply broadly. The therapy is non-invasive but may not outperform standard care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 44 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Jul 2026
An estimate. Start dates often move.
- Expected to finish
-
Dec 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
30 to 50 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Cervicobrachial pain * Females and males * Aged 30-50 years * Able to communicate and follow the instructions * Able to perform cervical exercises according to cervicogenic pain Exclusion Criteria: * Negative neurodynamic test * Neck and upper extremity surgery * Vertebral instability * Vertebral spine infection * Neurological disease of genetic, infection, or neuroplastic origin * Inflammatory or systemic disease * VBI symptoms * Rheumatoid arthritis * Subjects with presence of any fractures. * Heart/diabetic patient
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Cervico brachialgia are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.